dasatinib monohydrate
SpainDrugs containing this active substance
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast crisis CML in adults who have not responded to previous treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 100 mg Manufacturer: Teva B.V.
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 50 mg Manufacturer: Teva B.V.
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 70 mg Manufacturer: Teva B.V.
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 20 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and blast crisis CML in adults who have not responded to other treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 50 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast-phase CML in adults who have not responded to prior treatments.
Form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 70 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig